thestreet reaffirmed their buy rating on shares of CVS Caremark (NYSE: CVS) in a research note released on Friday morning.
“CVS Caremark (CVS) has been reiterated by TheStreet Ratings as a buy with a ratings score of A+ . The company’s strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.”
,” TheStreet’s analyst commented.
CVS Caremark traded up 1.41% on Friday, hitting $51.72. CVS Caremark has a 1-year low of $42.43 and a 1-year high of $52.73. The stock’s 50-day moving average is currently $50.53. The company has a market cap of $64.479 billion and a price-to-earnings ratio of 17.32.
CVS has been the subject of a number of other recent research reports. Analysts at Lazard Capital Markets reiterated a buy rating on shares of CVS Caremark in a research note to investors on Tuesday, January 29th. They now have a $58.00 price target on the stock. Separately, analysts at Jefferies Group reiterated a buy rating on shares of CVS Caremark in a research note to investors on Wednesday, January 23rd. They now have a $58.00 price target on the stock. Finally, analysts at JPMorgan Chase reiterated an overweight rating on shares of CVS Caremark in a research note to investors on Friday, January 4th. They now have a $59.00 price target on the stock.
Twenty-one investment analysts have rated the stock with a buy rating, two have assigned an overweight rating, and two have issued a hold rating to the stock. The stock presently has an average rating of buy and an average price target of $56.55.